Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2010
08/26/2010US20100216175 Condensate Glucose Analyzer
08/26/2010US20100216173 Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
08/26/2010US20100216172 Flow-based enhancement of specificity for label-free biochemical assays
08/26/2010US20100216171 Reducing Time to Result for Blood Bank Diagnostic Testing
08/26/2010US20100216170 Methods for identifying immunobinders of cell-surface antigens
08/26/2010US20100216169 Method for Detecting and Prognosing Pre-Cancerous Cells Using 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
08/26/2010US20100216168 Methods for evaluating angiogenic potential in culture
08/26/2010US20100216167 Methods for relieving neuropathic pain by modulating alpha 1g t-type calcium channels and mice lacking alpha 1g t-type calcium channels
08/26/2010US20100216166 Target activated microtransfer
08/26/2010US20100216165 Use of soluble forms of the desmoglein i protein for the purposes of screening for anti-ageing active agents
08/26/2010US20100216164 Mammalian prickle gene
08/26/2010US20100216163 Lectin-based glycan assay
08/26/2010US20100216162 Immunological Method, Test Kit and Device for the Determination of the Analyte Content of a Sample
08/26/2010US20100216161 Method for identifying protease inhibitors
08/26/2010US20100216160 Method for the screening proteasome of activity-modulating agents and means for carryiing out said method
08/26/2010US20100216159 Switchable affinity binders
08/26/2010US20100216158 Diagnostic test for head and facial pain
08/26/2010US20100216157 Immunoglobulin peptides against heated bovine blood
08/26/2010US20100216156 Cancer markers
08/26/2010US20100216154 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
08/26/2010US20100216150 Method for Identifying a Compound That Modulates Telomerase Activity
08/26/2010US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor
08/26/2010US20100216132 Methods and compositions for direct detection of dna damage
08/26/2010US20100216128 Methods for analyzing agricultural and environmental samples
08/26/2010US20100216126 Microfluidic device
08/26/2010US20100216118 Method of Detection/Extraction, and Related Detection/Extraction Device
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215677 Pdz domain interactions and lipid rafts
08/26/2010US20100215670 Immunotoxin Fusions Comprising An Antibody Fragment and a Plant Toxin Linked by Protease Cleavable Linkers
08/26/2010US20100215669 Anti-cd79b antibodies and immunoconjugates and methods of use
08/26/2010US20100215665 Mixed lineage kinases and metabolic disorders
08/26/2010US20100215663 Methods and compositions for regulation of neurological conditions
08/26/2010US20100215648 Detecting Agent and Therapeutic Agent for Highly Malignant Breast Cancer
08/26/2010US20100215647 Immunological Compositions as Cancer Biomarkers and/or Therapeutics
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215644 Analysis of nodes in cellular pathways
08/26/2010US20100215639 Chlamydia Pneumoniae Associated Chronic Intraocular Disorders and Treatment Thereof
08/26/2010US20100215638 Method for treatment of prostate cancer and screening of patients benefiting from said method
08/26/2010US20100215637 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215573 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
08/26/2010US20100215543 Methods for fabricating high aspect ratio probes and deforming high aspect ratio nanopillars and micropillars
08/26/2010US20100214558 Inspection instrument
08/26/2010US20100213081 Apparatus and method for detecting presence or determining biologically specifically reactive substance
08/26/2010US20100213080 System and method for the electrochemical measurement of an analyte employing a remote sensor
08/26/2010US20100213079 Microsecond response electrochemical sensors and methods thereof
08/26/2010US20100213074 Method of hormone extraction using digital microfluidics
08/26/2010US20100213061 Medical diagnosis; electrospraying alpha rays; radiation power sources; particle counting; measuring density distribution; for analyzing noncovalently bonded agglomerated biological particles; hyperlipidemia
08/26/2010US20100213058 Biosensor Membranes
08/26/2010US20100212406 Collection of dissolved gases from groundwater
08/26/2010US20100212213 Detection device and method for monitoring bed bug infestation
08/26/2010DE202010007616U1 Vorrichtung zur Kalibrierung von Atemalkoholmessgeräten Apparatus for calibration of alcohol breath testing devices
08/26/2010DE202009017886U1 Vorrichtung zur Partikelmessung in stark mit Gas, insbesondere Luft beladenem Medium Apparatus for particle measurement in strongly with gas, in particular air laden medium
08/26/2010DE112008002728T5 Systeme und Verfahren zum Verbessern von Lieferstrassenzuständen Systems and methods for improving the delivery of road conditions
08/26/2010DE102009034840A1 Verfahren und Systeme zum Vorhersagen von Ermüdungseigenschaften bei sehr hohen Zyklenzahlen in Metalllegierungen Methods and systems for predicting fatigue properties at very high cycle numbers in metal alloys
08/26/2010DE102009010563A1 Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten An apparatus for detecting analytes in body fluids
08/26/2010DE102009009228A1 Agglutination-based detection of disease comprises adding substrate of buffer, measuring initial intensity of buffer, diluting blood sample with buffer, measuring reference intensity and originating test person with disease to diagnose
08/26/2010DE102009001026A1 Verfahren und Messvorrichtung zur optischen Erfassung und Auswertung einer Fasern beinhaltenden Bahn Method and apparatus for measuring optical detection and evaluation of a fiber-containing web
08/26/2010DE102004056794B4 Verwendung einer Anordnung und Verfahren zur Validierung von Bindern Use of an arrangement and method for validation of binders
08/26/2010DE102004044717B4 Verfahren und Kit zur Kalibrierung eines Photolumineszenzmesssystems Method and kit for calibrating a photoluminescence
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2753269A1 Multiplex assay methods and compositions
08/26/2010CA2753198A1 Protein structural biomarkers to guide targeted chemotherapies
08/26/2010CA2753169A1 Nucleic acids specifically binding with human factor vii/viia and uses thereof
08/26/2010CA2753095A1 Detecting a mineral within a material
08/26/2010CA2753062A1 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752878A1 Optical tomography system with high-speed scanner
08/26/2010CA2752854A1 Quenched dendrimeric dyes for bright detection
08/26/2010CA2752845A1 Use of vgii3 activity modulator for the modulation of adipogenesis
08/26/2010CA2752718A1 Gdf15 as a differential marker for spondyloarthropathy
08/26/2010CA2752679A1 Isolated monocyte populations and related therapeutic applications
08/26/2010CA2752584A1 Specific binding proteins and uses thereof
08/26/2010CA2752512A1 Non-invasive biomedical detection and monitoring systems
08/26/2010CA2752510A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/26/2010CA2752171A1 Method for inhibiting neurodegeneration
08/26/2010CA2752126A1 Allergen detection method using immunochromatography
08/26/2010CA2746928A1 An apparatus for the measurement of a concentration of a charged species in a sample
08/26/2010CA2742265A1 Galectin-3 immunoassay
08/26/2010CA2742074A1 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
08/26/2010CA2729593A1 B7-h3 as a biomarker for diagnosing the progression and early lymph node metastasis of cancer
08/25/2010EP2221621A1 Test strip and method for determining HDL cholesterol concentration from whole blood or plasma
08/25/2010EP2221620A2 Polypeptide biomarkers for diagnosing Alzheimer's disease
08/25/2010EP2221619A1 Anti-drug antibody assay
08/25/2010EP2221618A2 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disase in hematologic malignancies
08/25/2010EP2221616A2 Liquid chromatography apparatus
08/25/2010EP2221611A1 System for monitoring quality of cooking oil
08/25/2010EP2221607A1 Method and measuring device for optical recording and evaluation of sheet containing fibres
08/25/2010EP2221603A1 Sensing device for detecting a target substance
08/25/2010EP2221385A2 Deubiquination assays
08/25/2010EP2221369A1 Mutant nucleic acid related to chronic myeloproliferative disorder, and method of evaluating chronic myeloproliferative disorder
08/25/2010EP2221363A1 System for the cell and development stage-specific selection of differentiating non-human embryonal stem cells, non-human embryonal germ cells, and adult stem cells
08/25/2010EP2221347A1 Sulfonated diarylrhodamine dyes
08/25/2010EP2221317A2 PEGylated single domain antibodies (dAb)
08/25/2010EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease
08/25/2010EP2221315A1 Methods of generating variant proteins with increased host string content and compositions thereof
08/25/2010EP2221105A2 Sample Well Strip
08/25/2010EP2221066A1 Use of VgII3 activity modulator for the modulation of adipogenesis
08/25/2010EP2221065A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
1 ... 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 ... 3937